Advertisement

Topics

Drug Combo Wins OK as First Line in Kidney Cancer

10:45 EDT 16 Apr 2018 | MedPageToday

(MedPage Today) -- As shown in Checkmate 214 study, ipilimumab + nivolumab improve survival

Original Article: Drug Combo Wins OK as First Line in Kidney Cancer

NEXT ARTICLE

More From BioPortfolio on "Drug Combo Wins OK as First Line in Kidney Cancer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Monoclonal antibodies MAbs
Monoclonal antibodies recognise and attach to specific proteins produced by cells.  Types of monoclonal antibodies used to treat cancer cells: Block cell dividing dividing signals Transport cancer drugs or radiation to cancer cells Tr...